(2025). Mirtazapine for gastrointestinal side effects of glucagon-like peptide-1 receptor agonist therapy in older adults. Endocrine Regulations.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Mirtazapine for Gastrointestinal Side Effects of Glucagon-like Peptide-1 Receptor Agonist Therapy in Older Adults."
Endocrine Regulations 2025.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Mirtazapine for Gastrointestinal Side Effects of Glucagon-like Peptide-1 Receptor Agonist Therapy in Older Adults."
Endocrine Regulations, 2025.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.